New Gene Therapy Could Face Uphill Battle
Wall Street Journal
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could be slow.
https://www.wsj.com/articles/new-gene-therapy-could-face-uphill-battle-aa0f36e6